Lack of Clinically Relevant Drug–Drug Interaction Between Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Verapamil, Ramipril, or Digoxin in Healthy Volunteers

✍ Scribed by Macha, Sreeraj; Sennewald, Regina; Rose, Peter; Schoene, Katja; Pinnetti, Sabine; Woerle, Hans J.; Broedl, Uli C.

• Book ID: 120591429
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 520 KB
• Volume: 35
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2013.02.015